Erratum for Exposure to Concentrated Ambient Fine Particulate Matter Induces Vascular Endothelial Dysfunction via miR (Int J Biol Sci 2017; 13(7): 868-877. 10.7150/ijbs.19868.);Exposure to concentrated ambient fine particulate matter induces vascular endothelial dysfunction via miR-21

International Journal of Biological Sciences

Volumn 13, Issue 7, 2017, Pages 868-877

  Dai, Jianwei ^a,b   Chen, Wensheng ^a   Lin, Yuyin ^a   Wang, Shiwen ^a   Guo, Xiaolan ^a   Zhang, Qian Qian ^c  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Fine particulate matter; MiR 21; Permeability; Vascular endothelial cell

Indexed keywords

CADHERIN; GELATINASE B; MICRORNA; MIRN21 MICRORNA, RAT; MMP9 PROTEIN, RAT; STAT3 PROTEIN; STAT3 PROTEIN, RAT; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ANIMAL; CAPILLARY PERMEABILITY; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PARTICLE SIZE; PARTICULATE MATTER; RAT; SPRAGUE DAWLEY RAT; THORACIC AORTA; TOXICITY; VASCULAR ENDOTHELIUM;

ANIMALS; AORTA, THORACIC; CADHERINS; CAPILLARY PERMEABILITY; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; MALE; MATRIX METALLOPROTEINASE 9; MICRORNAS; PARTICLE SIZE; PARTICULATE MATTER; RATS; RATS, SPRAGUE-DAWLEY; STAT3 TRANSCRIPTION FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE-3;

EID: 85025160693     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.69524     Document Type: Erratum

References (44)

1. M. D. McDonald, Baluk P. Significance of Blood Vessel Leakiness in Cancer. CANCER RESEARCH. 2002; 62: 5381–5.
2. van Hinsbergh VWM, van Nieuw Amerongen GP. Endothelial hyperpermeability in vascular leakage. Vascular Pharmacology. 2002; 39: 171-2.
3. Vincent J D Krouwer, Liesbeth H P Hekking, Miriam Langelaar-Makkinje, Elsa Regan-Klapisz, Post JA. Endothelial cell senescence is associated with disrupted cell-cell junctions and increased monolayer permeability. Krouwer et al Vascular Cell. 2012; 4: 12.
4. Aslan A, van Meurs M, Moser J, et al. Organ-Specific Differences in Endothelial Permeability-Regulating Molecular Responses in Mouse and Human Sepsis. Shock. 2017.
5. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circulation research. 2003; 92: 827-39.
6. Murphy G, Nguyenl Q, Cockettll MI, et al. Assessment of the Role of the Fibronectin-like Domain of Gelatinase A by Analysis of a Deletion Muta. BIO-ICACLHE MIFIXY. 1994; 269: 6632-6,.
7. Shipley JM, Doyle GAR, Fliszar CJ, et al. The Structural Basis for the Elastolytic Activity of the 92-kDa and 72-kDa Gelatinases. BIOLOGICAL CHEMISTRY. 1996; 271: 4335–41.
8. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010; 141: 52-67.
9. Mishra A, Paul S, Swarnakar S. Downregulation of matrix metalloproteinase-9 by melatonin during prevention of alcohol-induced liver injury in mice. Biochimie. 2011; 93: 854-66.
10. Ye D, Guo S, Al-Sadi R, Ma TY. MicroRNA regulation of intestinal epithelial tight junction permeability. Gastroenterology. 2011; 141: 1323-33.
11. Cho WC. OncomiRs: the discovery and progress of microRNAs in cancers. Molecular cancer. 2007; 6: 60.
12. McGuinn LA, Ward-Caviness CK, Neas LM MiRNAs and their potential for use against cancer and other diseases. 2007.
13. Chen SZ, Ning LF, Xu X, et al. The miR-181d-regulated metalloproteinase Adamts1 enzymatically impairs adipogenesis via ECM remodeling. Cell Death and Differentiation. 2016; 23: 1778-91.
14. Dai J, Sun C, Yao Z, Chen W, Yu L, Long M. Exposure to concentrated ambient fine particulate matter disrupts vascular endothelial cell barrier function via the IL-6/HIF-1alpha signaling pathway. FEBS open bio. 2016; 6: 720-8.
15. Marin V, Kaplanski G, Gres S, Farnarier C, Bongrand P. Endothelial cell culture: protocol to obtain and cultivate human umbilical endothelial cells. Journal of immunological methods. 2001; 254: 183-90.
16. Menge T, Zhao Y, Zhao J, et al. Mesenchymal stem cells regulate blood-brain barrier integrity through TIMP3 release after traumatic brain injury. Science translational medicine. 2012; 4: 161ra50.
17. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nature protocols. 2008; 3: 1101-8.
18. Xu H, He JH, Xiao ZD, et al. Liver-enriched transcription factors regulate microRNA-122 that targets CUTL1 during liver development. Hepatology. 2010; 52: 1431-42.
19. Chatterjee V, Beard RS, Jr., Reynolds JJ, et al. MicroRNA-147b regulates vascular endothelial barrier function by targeting ADAM15 expression. PloS one. 2014; 9: e110286.
20. Hu J, Ni S, Cao Y, et al. The Angiogenic Effect of microRNA-21 Targeting TIMP3 through the Regulation of MMP2 and MMP9. PloS one. 2016; 11: e0149537.
21. Arpino V, Mehta S, Wang L, et al. Tissue inhibitor of metalloproteinases 3-dependent microvascular endothelial cell barrier function is disrupted under septic conditions. American journal of physiology Heart and circulatory physiology. 2016; 310: H1455-67.
22. Munjal C, Tyagi N, Lominadze D, Tyagi SC. Matrix metalloproteinase-9 in homocysteine-induced intestinal microvascular endothelial paracellular and transcellular permeability. Journal of cellular biochemistry. 2012; 113: 1159-69.
23. Fainaru O, Adini I, Benny O, et al. Doxycycline induces membrane expression of VE-cadherin on endothelial cells and prevents vascular hyperpermeability. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2008; 22: 3728-35.
24. Hebda JK, Leclair HM, Azzi S, et al. The C-terminus region of beta-arrestin1 modulates VE-cadherin expression and endothelial cell permeability. Cell communication and signaling: CCS. 2013; 11: 37.
25. Sun SS, Zhou X, Huang YY, et al. Targeting STAT3/miR-21 axis inhibits epithelial-mesenchymal transition via regulating CDK5 in head and neck squamous cell carcinoma. Molecular cancer. 2015; 14: 213.
26. Huo W, Zhao G, Yin J, et al. Lentiviral CRISPR/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells. Journal of Cancer. 2017; 8: 57-64.
27. Iliopoulos D, Jaeger SA, Hirsch HA, Bulyk ML, Struhl K. STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Molecular cell. 2010; 39: 493-506.
28. Davel AP, Lemos M, Pastro LM, et al. Endothelial dysfunction in the pulmonary artery induced by concentrated fine particulate matter exposure is associated with local but not systemic inflammation. Toxicology. 2012; 295: 39-46.
29. Nurkiewicz TR, Porter DW, Barger M, et al. Systemic microvascular dysfunction and inflammation after pulmonary particulate matter exposure. Environmental health perspectives. 2006; 114: 412-9.
30. Kampfrath T, Maiseyeu A, Ying Z, et al. Chronic fine particulate matter exposure induces systemic vascular dysfunction via NADPH oxidase and TLR4 pathways. Circulation research. 2011; 108: 716-26.
31. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 2000; 101: 1899-906.
32. Brunner H, Cockcroft JR, Deanfield J, et al. Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. Journal of hypertension. 2005; 23: 233-46.
33. Christensen HM, Schou M, Goetze JP, et al. Body mass index in chronic heart failure: association with biomarkers of neurohormonal activation, inflammation and endothelial dysfunction. BMC cardiovascular disorders. 2013; 13: 80.
34. Sima AV, Stancu CS, Simionescu M. Vascular endothelium in atherosclerosis. Cell and tissue research. 2009; 335: 191-203.
35. Liu ZL, Wang H, Liu J, Wang ZX. MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN. Molecular and cellular biochemistry. 2013; 372: 35-45.
36. Qi M, Liu D, Zhang S. MicroRNA-21 contributes to the discrimination of chemoresistance in metastatic gastric cancer. Cancer biomarkers: section A of Disease markers. 2017.
37. Yang Y, Guo JX, Shao ZQ. miR-21 targets and inhibits tumor suppressor gene PTEN to promote prostate cancer cell proliferation and invasion: An experimental study. Asian Pacific journal of tropical medicine. 2017; 10: 87-91.
38. Thum T, Gross C, Fiedler J, et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature. 2008; 456: 980-4.
39. Patrick DM, Montgomery RL, Qi X, et al. Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. The Journal of clinical investigation. 2010; 120: 3912-6.
40. Dong S, Cheng Y, Yang J, et al. MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. The Journal of biological chemistry. 2009; 284: 29514-25.
41. Liu LZ, Li C, Chen Q, et al. MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1alpha expression. PloS one. 2011; 6: e19139.
42. Louwies T, Vuegen C, Panis LI, et al. miRNA expression profiles and retinal blood vessel calibers are associated with short-term particulate matter air pollution exposure. Environmental research. 2016; 147: 24-31.
43. Zhang L, Shen J, Cheng J, Fan X. MicroRNA-21 regulates intestinal epithelial tight junction permeability. Cell biochemistry and function. 2015; 33: 235-40.
44. Corada M, Liao F, Lindgren M, et al. Monoclonal antibodies directed to different regions of vascular endothelial cadherin extracellular domain affect adhesion and clustering of the protein and modulate endothelial permeability. Blood. 2001; 97: 1679-84.